Fractal, an AI solutions provider enterprise, has announced a strategic $20 million investment in Asper.AI, one of its product ventures specialising in AI-driven growth solutions for consumer goods and manufacturing. The funding aims to accelerate Asper.AI’s global expansion, drive product innovation, and scale its enterprise client base.
Asper.AI focuses on transforming business decision-making through AI, covering key areas such as demand forecasting, revenue growth management, inventory planning, and sales execution. With operations spanning Bengaluru, New York, London, and San Francisco, the company is dedicated to delivering AI-powered insights that optimize business performance.
Pranay Agrawal, co-founder and CEO of Fractal, praised Asper.AI’s rapid progress, stating, “Asper has achieved remarkable growth and innovation within just three years. We are excited to strengthen our partnership and support Asper’s next phase of expansion. This investment will unlock new opportunities for enterprise clients worldwide.”
Also Read :- Google to acquire Wiz for $32 Billion
Mohit Agarwal, Co-founder and CEO of Asper.AI, emphasised that businesses require more than just AI—they need intelligent solutions that integrate seamlessly with operations and translate data into actionable decisions. “With Fractal’s investment, we will enhance our autonomous growth AI platform, attract top talent, and expand our product suite to meet the growing demand for AI-powered business solutions,” he added.
Asper.AI recognises that scaling AI solutions in consumer goods and manufacturing requires significant investment in AI expertise, infrastructure, and ongoing model training.
Fractal, established in 2022, has been at the forefront of AI adoption among Fortune 500 companies. It has built a diverse AI-driven portfolio, including Asper.AI, Flyfish (a GenAI platform for search and product discovery), and Analytics Vidhya (a leading data science community). The company also incubated Qure.ai, a healthcare AI venture focused on detecting tuberculosis, lung cancer, and strokes.
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter.
"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!
